➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Dow
Medtronic
Mallinckrodt
Boehringer Ingelheim

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Litigation Details for Carnegie Institution of Washington v. Pure Grown Diamonds, Inc. (S.D.N.Y. 2020)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Carnegie Institution of Washington v. Pure Grown Diamonds, Inc. (S.D.N.Y. 2020)

Docket   Start Trial Date Filed 2020-01-09
Court District Court, S.D. New York Date Terminated
Cause 35:271 Patent Infringement Assigned To Jed Saul Rakoff
Jury Demand Plaintiff Referred To
Parties CARNEGIE INSTITUTION OF WASHINGTON; IIA TECHNOLOGIES PTE. LTD; M7D CORPORATION; PURE GROWN DIAMONDS, INC.
Patents 10,010,498; 10,011,857; 10,023,854; 10,065,919; 10,071,992; 10,076,523; 10,076,557; 10,076,573; 10,092,557; 10,092,569; 10,118,901; 10,138,288; 10,172,380; 10,189,818; 10,206,939; 10,256,050; 10,287,362; 10,336,809; 10,336,815; 10,336,827; 10,420,775; 10,434,039; 10,434,147; 10,450,613; 10,479,686; 10,544,200; 10,557,175; 10,557,862; 10,563,189; 10,563,271; 10,570,202; 10,576,111; 10,576,136; 10,613,085; 10,613,091; 10,613,092; 10,613,101; 6,004,596; 6,010,737; 6,171,575; 6,172,031; 6,566,135; 6,735,998; 6,737,006; 6,858,409; 6,858,584; 6,858,618; 6,863,185; 6,869,939; 6,900,175; 6,927,192; 6,992,070; 6,992,085; 6,992,102; 6,992,110; 7,014,610; 7,037,889; 7,087,613; 7,090,618; 7,101,576; 7,132,408; 7,135,618; 7,147,067; 7,192,612; 7,217,569; 7,217,858; 7,288,408; 7,393,674; 7,408,024; 7,415,858; 7,452,867; 7,517,900; 7,537,009; 7,544,370; 7,544,860; 7,544,863; 7,550,153; 7,550,575; 7,557,266; 7,563,801; 7,563,871; 7,566,690; 7,566,714; 7,566,816; 7,576,053; 7,610,097; 7,662,125; 7,662,141; 7,662,573; 7,662,858; 7,674,774; 7,678,399; 7,714,185; 7,745,571; 7,754,271; 7,811,185; 7,811,618; 7,818,100; 7,838,009; 7,838,027; 7,838,498; 7,858,087; 7,858,118; 7,858,122; 7,858,139; 7,858,662; 7,858,845; 7,883,714; 7,918,823; 7,932,009; 7,939,086; 7,939,714; 7,976,590; 7,981,618; 7,989,412; 8,003,353; 8,017,557; 8,017,839; 8,030,523; 8,048,854; 8,057,811; 8,057,818; 8,057,998; 8,071,569; 8,071,613; 8,075,919; 8,101,429; 8,101,818; 8,105,613; 8,124,573; 8,137,992; 8,206,735; 8,208,189; 8,282,909; 8,318,202; 8,362,288; 8,372,995; 8,399,015; 8,426,362; 8,439,864; 8,551,773; 8,556,864; 8,563,690; 8,569,061; 8,569,072; 8,569,573; 8,575,434; 8,618,049; 8,618,076; 8,618,081; 8,618,123; 8,618,130; 8,618,135; 8,618,141; 8,618,289; 8,662,130; 8,692,006; 8,692,008; 8,703,379; 8,735,076; 8,735,428; 8,748,413; 8,754,072; 8,754,078; 8,754,090; 8,754,091; 8,754,096; 8,754,123; 8,808,786; 8,809,271; 8,809,615; 8,858,939; 8,858,987; 8,859,610; 8,883,775; 8,889,099; 8,889,109; 8,889,113; 8,889,115; 8,889,136; 8,889,932; 8,892,681; 8,900,333; 8,900,566; 8,900,576; 8,900,618; 8,901,086; 8,933,191; 8,998,754; 9,000,002; 9,005,613; 9,011,906; 9,011,949; 9,012,418; 9,060,708; 9,060,939; 9,060,992; 9,066,992; 9,067,992; 9,073,858; 9,089,570; 9,089,618; 9,096,569; 9,102,573; 9,109,992; 9,125,889; 9,125,939; 9,161,992; 9,261,522; 9,327,175; 9,370,557; 9,399,023; 9,408,858; 9,408,973; 9,415,102; 9,415,136; 9,446,013; 9,446,057; 9,446,998; 9,511,031; 9,523,099; 9,566,271; 9,566,289; 9,573,818; 9,573,921; 9,580,739; 9,598,707; 9,662,415; 9,662,450; 9,700,050; 9,708,618; 9,714,283; 9,737,399; 9,738,690; 9,739,786; 9,808,444; 9,808,517; 9,815,827; 9,839,688; 9,839,692; 9,889,102; 9,889,118; 9,889,138; 9,901,113; 9,902,714; 9,902,745; 9,909,047; 9,913,902; 9,918,654; 9,918,939; 9,919,048; 9,919,050
Attorneys Amy Simpson; Jonathon Brugh Lower; Joseph Preston Long; Matthew Joseph Moffa; Parmanand K. Sharma; Terrence Wikberg; William Paul Deni , Jr.,
Firms Finnegan Henderson Farabow Garrett & Dunner LLP-DC; Finnegan Henderson Farabow Garrett and Dunner; Perkins Coie LLP
Link to Docket External link to docket
Biologic Drugs cited in Carnegie Institution of Washington v. Pure Grown Diamonds, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Carnegie Institution of Washington v. Pure Grown Diamonds, Inc. (S.D.N.Y. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-03-30 29 Memorandum of Law in Support of Motion Mail’s patents themselves.”); Automated Tracking Solutions, LLC v. Coca-Cola Co., 723 F. App’x 989, 995…........16 Exhibit J at 1:27-36 U.S. Patent No. 5,449,412 to Pinneo ..............................… and ’189 Patents because Devi Shankar Misra is “a named inventor on at least seven patents relating …Exhibit A at 1:20-22, 4:57-5:30, 6:40-50, 7:8-10, Fig. 1 U.S. Patent No. 4,124,690 to Strong et al. .....…2200ºC @ 7 GPa), Fig. 1 (showing HPHT conditions). To suggest this difference is patentable would be, External link to document
2020-04-13 36 Memorandum of Law in Opposition to Motion ” infringement. 189 F. Supp. 3d at 775. And L-7 was a non-patent case where the only specific allegation…diamond stable phase. ECF No.1-2 (“the ’189 patent”) at 4:10–14. C. Procedural Background …36 Filed 04/13/20 Page 10 of 32 annealing processes claimed in the ’189 patent, id. ¶¶ 81–86, 118–21… also patent-eligible. As the Patent and Trademark Office has explained in its Manual of Patent Examining…Materials, Inc. v. Mitsubishi Materials Silicon Corp., 420 F.3d 1369 (Fed Cir. 2005)........................ External link to document
2020-04-17 38 Brief Found. v. Genentech, Inc., 927 F.2d 1565, 1580 (Fed. Cir. 1991). The ’078 Patent demonstrates no intention…..... 1 II. DISPUTED CLAIM TERMS IN U.S. PATENT NO. 6,858,078.....................................… CLAIM TERM IN U.S. PATENT NO. RE41,189......................................... 6 A. “…................ 6 IV. SIMILAR DISPUTED CLAIM TERMS IN THE ’078 AND ’189 PATENTS ............... 10…constructions. II. DISPUTED CLAIM TERMS IN U.S. PATENT NO. 6,858,078 A. “controlling temperature External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Merck
Colorcon
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.